|Articles|June 19, 2006

Applied Clinical Trials

  • Applied Clinical Trials-06-20-2006
  • Volume 0
  • Issue 0

Keynote Address: Making Medicine Meaningful

Dr. Sanjay Gupta, senior medical correspondent for CNN, practicing neurosurgeon, and assistant professor of neurosurgery, delivered the Keynote Address at the 42nd DIA Annual Meeting on Monday morning.

Dr. Sanjay Gupta, senior medical correspondent for CNN, practicing neurosurgeon, and assistant professor of neurosurgery, delivered the Keynote Address at the 42nd DIA Annual Meeting on Monday morning, stating that the ultimate goal of communicating medical topics is to "make the lives of people better, fuller, and longer."

Recounting his experiences in Iraq during the Gulf War, Southeast Asia during the tsunami, and most recently, in hurricane-ravaged New Orleans, Gupta said he always asks, "Why does it matter to the millions of people who are watching?" To make health information relevant, he said, a medical communicator must work hard to translate health information into knowledge into contexts that people can use.

Currently, he is interested in the issues of childhood obesity in the United States and the way the media communicates changes to the U.S. Medicare system.


Related to this article

© C Davids/peopleimages.com - © C Davids/peopleimages.com - stock.adobe.com
The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.